News
Esketamine monotherapy is linked to greater 28-day symptom reduction in treatment-resistant depression vs placebo, new research shows.
Centessa Pharmaceuticals (NASDAQ:CNTA) is one of the best low priced pharma stocks to buy now. On July 4, Nxera Pharma Co.
Karen Peterson was diagnosed with stage 1 triple-negative breast cancer that quickly returned as stage 4. Joining a clinical ...
SINGAPORE: Researchers in Singapore have received a S$25 million grant to work on tackling lung cancer in Asian patients ...
7h
AllAfrica on MSNMomentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To ActionNew WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
The therapeutic landscape for hormone receptor-positive (HR+) advanced breast cancer (BC) is moving from generalized ...
Chemoradiation combined with immunotherapy significantly boosts survival in patients with resected extrahepatic ...
NextShark Ventures is proud to welcome Remission Biotech as the latest addition to its portfolio of companies redefining the ...
Charleigh Pollock’s mother says she hopes private funding will get her daughter through the summer months, after the province ...
MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering allogeneic, off-the-shelf invariant natural killer T (iNKT) cell ...
10h
ABC4 Utah on MSN‘I would do it again’ — Doctor accused of COVID vaccine scheme speaks out after charges were droppedI didn’t advertise anything. I didn’t make anybody come in. It was all word of mouth,” he explained. “It was all their– you ...
PCI Pharma Services (“PCI” or the “Company”), a world-leading global contract development and manufacturing organization (CDMO) focused on innovative biotherapies, today announced that it received a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results